200+ total transactions representing $100B+ in aggregate value — 18 tracked below spanning 2015–2025 · 3 industries
Advisor on acquisition of life science biomarker company by Standard BioTools expanding diagnostic capabilities.
Advisor on Actigraph divestiture of Biofourmis business, separating wearable sensor and digital health assets.
Advisor on Bio-Techne divestiture of biological products subsidiary to focused buyer.
Advisor on Series C funding round for integrated research organization (IRO) delivering clinical trials at point of care. Funding supports expansion into oncology, CNS, and neurology therapeutic areas with access to 5M+ patients across 7 states.
Buy-side advisor to LongueVue Capital's portfolio company Pinnacle on acquisition of CNS-focused clinical research site. KMC founded by Dr. Diana Kerwin, leading Alzheimer's disease research opinion leader.
Buy-side advisor to LongueVue Capital on acquisition of CNS-focused clinical research site expanding Pinnacle's Alzheimer's Disease expertise across Northeast.
Advisor on acquisition of clinical trial services company expanding Versiti's clinical trial capabilities.
Advisor on acquisition of vaccine and clinical trial site network by PE-backed Emmes expanding vaccine and clinical trial capabilities.
Advisor on acquisition of healthcare solutions company by PE-backed Acuvance.
Advisor on institutional review board acquisition by PE-backed Sabai Global expanding IRB capabilities.
Advisor on patient engagement platform acquisition bolstering Spectrum Science's clinical capabilities.
Advisor on preclinical services company acquisition expanding Janvier Group's service offering internationally.
Advisor on pharmaceutical clinical packaging, distribution, and bioservices acquisition combining capabilities to serve pharmaceutical and biotech companies in clinical and commercial stages, including Advanced Therapies.
Advisor on acquisition of clinical trial patient recruitment AI platform by Tempus AI, advancing patient access for clinical research.
Advisor on acquisition of healthcare software platform by PE-backed RLDatix combining patient engagement and data analytics capabilities.
Advisor on eClinical software platform acquisition by Valsoft Corporation for commercialization capabilities.